NO175405C - Fremgangsmåte for fremstilling av et farmasöytisk preparat med sakte frigivelse, som ikke er et injeksjonsfluid - Google Patents
Fremgangsmåte for fremstilling av et farmasöytisk preparat med sakte frigivelse, som ikke er et injeksjonsfluidInfo
- Publication number
- NO175405C NO175405C NO881296A NO881296A NO175405C NO 175405 C NO175405 C NO 175405C NO 881296 A NO881296 A NO 881296A NO 881296 A NO881296 A NO 881296A NO 175405 C NO175405 C NO 175405C
- Authority
- NO
- Norway
- Prior art keywords
- release pharmaceutical
- slow
- pharmaceutical composition
- release
- preparation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5015—Organic compounds, e.g. fats, sugars
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6967787 | 1987-03-24 |
Publications (4)
Publication Number | Publication Date |
---|---|
NO881296D0 NO881296D0 (no) | 1988-03-24 |
NO881296L NO881296L (no) | 1988-09-26 |
NO175405B NO175405B (no) | 1994-07-04 |
NO175405C true NO175405C (no) | 1994-10-12 |
Family
ID=13409722
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO881296A NO175405C (no) | 1987-03-24 | 1988-03-24 | Fremgangsmåte for fremstilling av et farmasöytisk preparat med sakte frigivelse, som ikke er et injeksjonsfluid |
Country Status (13)
Country | Link |
---|---|
US (1) | US5057317A (no) |
EP (1) | EP0284039B1 (no) |
KR (1) | KR960005141B1 (no) |
AT (1) | ATE78157T1 (no) |
AU (1) | AU603878B2 (no) |
CA (1) | CA1324081C (no) |
DE (1) | DE3872739T2 (no) |
DK (1) | DK174992B1 (no) |
ES (1) | ES2051782T3 (no) |
FI (1) | FI94094C (no) |
GR (1) | GR3005818T3 (no) |
IE (1) | IE62487B1 (no) |
NO (1) | NO175405C (no) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE68907066T2 (de) * | 1988-01-29 | 1993-12-16 | Koken Kk | Verbesserte Formulierungen mit kontrollierter Abgabe. |
US5352461A (en) * | 1992-03-11 | 1994-10-04 | Pharmaceutical Discovery Corporation | Self assembling diketopiperazine drug delivery system |
IT1256022B (it) * | 1992-06-08 | 1995-11-20 | Preparazioni farmaceutiche stabili di nicorandil | |
WO1993025221A1 (en) † | 1992-06-11 | 1993-12-23 | Alkermes Controlled Therapeutics, Inc. | Erythropoietin drug delivery system |
US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
GB9505032D0 (en) | 1995-03-13 | 1995-05-03 | Westminster Lab Ltd | Improvements in or relating to organic compositions |
US5543099A (en) * | 1994-09-29 | 1996-08-06 | Hallmark Pharmaceutical, Inc. | Process to manufacture micronized nifedipine granules for sustained release medicaments |
US5660848A (en) * | 1994-11-02 | 1997-08-26 | The Population Council, Center For Biomedical Research | Subdermally implantable device |
DE4444051A1 (de) * | 1994-12-10 | 1996-06-13 | Rhone Poulenc Rorer Gmbh | Pharmazeutische, oral anwendbare Zubereitung |
US5925658A (en) * | 1995-03-02 | 1999-07-20 | Sankyo Company, Limited | Optically active thiazolidinone derivative |
US5993856A (en) * | 1997-01-24 | 1999-11-30 | Femmepharma | Pharmaceutical preparations and methods for their administration |
US6416778B1 (en) | 1997-01-24 | 2002-07-09 | Femmepharma | Pharmaceutical preparations and methods for their regional administration |
EP1077065B1 (en) * | 1998-05-15 | 2004-08-04 | Chugai Seiyaku Kabushiki Kaisha | Controlled release formulations |
WO2000030446A1 (en) | 1998-11-23 | 2000-06-02 | Bonnie Davis | Dosage formulations for acetylcholinesterase inhibitors |
UA74141C2 (uk) | 1998-12-09 | 2005-11-15 | Дж.Д. Сірл Енд Ко. | Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти) |
US7018654B2 (en) * | 1999-03-05 | 2006-03-28 | New River Pharmaceuticals Inc. | Pharmaceutical composition containing an active agent in an amino acid copolymer structure |
US6716452B1 (en) | 2000-08-22 | 2004-04-06 | New River Pharmaceuticals Inc. | Active agent delivery systems and methods for protecting and administering active agents |
WO2000074720A1 (fr) * | 1999-06-09 | 2000-12-14 | Mochida Pharmaceutical Co., Ltd. | Systeme de liberation dans les voies digestives inferieures |
US8394813B2 (en) | 2000-11-14 | 2013-03-12 | Shire Llc | Active agent delivery systems and methods for protecting and administering active agents |
US20060014697A1 (en) | 2001-08-22 | 2006-01-19 | Travis Mickle | Pharmaceutical compositions for prevention of overdose or abuse |
US7169752B2 (en) | 2003-09-30 | 2007-01-30 | New River Pharmaceuticals Inc. | Compounds and compositions for prevention of overdose of oxycodone |
MXPA04006017A (es) * | 2001-12-20 | 2005-06-08 | Femmepharma Inc | Suministro de farmacos por via vaginal. |
US20090035260A1 (en) * | 2002-07-29 | 2009-02-05 | Therapicon Srl | Enhanced nasal composition of active peptide |
US9173836B2 (en) | 2003-01-02 | 2015-11-03 | FemmeParma Holding Company, Inc. | Pharmaceutical preparations for treatments of diseases and disorders of the breast |
EP1578421A4 (en) * | 2003-01-02 | 2009-04-22 | Femmepharma Holding Co Inc | PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF DISEASES AND BREAST CONDITIONS |
ITMI20040235A1 (it) * | 2004-02-13 | 2004-05-13 | Therapicon Srl | Preparazione farmaceutica per il cavo orale |
EP2104489A2 (en) * | 2006-12-26 | 2009-09-30 | FemmePharma Holding Company, Inc. | Topical administration of danazol |
US9486446B2 (en) * | 2006-12-28 | 2016-11-08 | Takeda Pharmaceutical Company Limited | Orally disintegrating solid preparation |
US20110003000A1 (en) * | 2009-07-06 | 2011-01-06 | Femmepharma Holding Company, Inc. | Transvaginal Delivery of Drugs |
JP2022529189A (ja) * | 2019-04-19 | 2022-06-17 | ホフマン・テクノロジーズ・エルエルシー | 持続放出製剤 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2753288A (en) * | 1953-01-12 | 1956-07-03 | Upjohn Co | Scopolamine lower-alkyl halide therapeutic composition |
US3477864A (en) * | 1965-05-07 | 1969-11-11 | Sumitomo Chemical Co | Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film |
GB1155036A (en) * | 1966-07-08 | 1969-06-11 | Ethan Allan Brown | Injectionable Substance |
US3541201A (en) * | 1968-12-18 | 1970-11-17 | Ethan Alan Brown | Novel sodium chloride encapsulated injectionable substances |
US3786123A (en) * | 1971-01-25 | 1974-01-15 | S Katzen | Method for stabilizing and preserving nutrients and products |
GB1377074A (en) * | 1971-07-13 | 1974-12-11 | Beecham Group Ltd | Process for preparing injectable compositions |
GB1492973A (en) * | 1974-02-16 | 1977-11-23 | Beecham Group Ltd | Process for preparing injectable compositions |
US4070455A (en) * | 1974-02-16 | 1978-01-24 | Beecham Group Limited | Process for preparing injectable desensitizing compositions and products thereof in microparticle form |
LU69456A1 (no) * | 1974-02-22 | 1975-12-09 | ||
DD146547A5 (de) * | 1978-07-15 | 1981-02-18 | Boehringer Sohn Ingelheim | Arzneimittel-retardform mit unloeslichen poroesen diffusionshuellen |
JPS5835110A (ja) * | 1981-08-28 | 1983-03-01 | Tetsuo Kato | 徐放性マイクロカプセル |
US4457907A (en) * | 1982-08-05 | 1984-07-03 | Clear Lake Development Group | Composition and method for protecting a therapeutic drug |
IT1177384B (it) * | 1984-12-12 | 1987-08-26 | Boeehringer Biochemia Robin Sp | Prodotti dietetici granulari a base di amminoacidi e procedimento per la loro preparazione |
US4863741A (en) * | 1985-03-25 | 1989-09-05 | Abbott Laboratories | Tablet composition for drug combinations |
US4695591A (en) * | 1985-03-29 | 1987-09-22 | Schering Corporation | Controlled release dosage forms comprising hydroxypropylmethylcellulose |
US5188840A (en) * | 1985-09-26 | 1993-02-23 | Chugai Seiyaku Kabushiki Kaisha | Slow-release pharmaceutical agent |
US4843071A (en) * | 1986-12-05 | 1989-06-27 | Serotonin Industries Of Charleston | Method and composition for treating obesity, drug abuse, and narcolepsy |
-
1988
- 1988-03-22 US US07/171,817 patent/US5057317A/en not_active Expired - Lifetime
- 1988-03-23 ES ES88104643T patent/ES2051782T3/es not_active Expired - Lifetime
- 1988-03-23 IE IE85588A patent/IE62487B1/en not_active IP Right Cessation
- 1988-03-23 DE DE8888104643T patent/DE3872739T2/de not_active Expired - Fee Related
- 1988-03-23 AU AU13517/88A patent/AU603878B2/en not_active Ceased
- 1988-03-23 AT AT88104643T patent/ATE78157T1/de not_active IP Right Cessation
- 1988-03-23 DK DK198801587A patent/DK174992B1/da not_active IP Right Cessation
- 1988-03-23 EP EP88104643A patent/EP0284039B1/en not_active Expired - Lifetime
- 1988-03-24 NO NO881296A patent/NO175405C/no unknown
- 1988-03-24 CA CA000562345A patent/CA1324081C/en not_active Expired - Fee Related
- 1988-03-24 FI FI881409A patent/FI94094C/fi not_active IP Right Cessation
- 1988-03-24 KR KR1019880003189A patent/KR960005141B1/ko not_active IP Right Cessation
-
1992
- 1992-09-29 GR GR920402149T patent/GR3005818T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
NO881296L (no) | 1988-09-26 |
FI94094B (fi) | 1995-04-13 |
ES2051782T3 (es) | 1994-07-01 |
NO175405B (no) | 1994-07-04 |
FI94094C (fi) | 1995-07-25 |
IE62487B1 (en) | 1995-02-08 |
KR960005141B1 (ko) | 1996-04-22 |
NO881296D0 (no) | 1988-03-24 |
DK174992B1 (da) | 2004-04-13 |
US5057317A (en) | 1991-10-15 |
IE880855L (en) | 1988-09-24 |
EP0284039A3 (en) | 1989-01-25 |
FI881409A0 (fi) | 1988-03-24 |
DK158788A (da) | 1988-09-25 |
GR3005818T3 (no) | 1993-06-07 |
EP0284039A2 (en) | 1988-09-28 |
AU1351788A (en) | 1988-09-29 |
KR880010758A (ko) | 1988-10-24 |
DE3872739D1 (de) | 1992-08-20 |
ATE78157T1 (de) | 1992-08-15 |
DK158788D0 (da) | 1988-03-23 |
DE3872739T2 (de) | 1993-01-21 |
AU603878B2 (en) | 1990-11-29 |
CA1324081C (en) | 1993-11-09 |
EP0284039B1 (en) | 1992-07-15 |
FI881409A (fi) | 1988-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO175405C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat med sakte frigivelse, som ikke er et injeksjonsfluid | |
NO175763C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat hvor DL-tryptofan, eventuelt i kombinasjon med fumarsyre, anvendes som hjelpestoffer | |
NO174412C (no) | Fremgangsmåte for fremstilling av en farmasöytisk formulering med programmert frigjöring for oral anvendelse | |
DE58906926D1 (de) | Neue Arzneimittelformulierung sowie Verfahren zu deren Herstellung. | |
DE69616795D1 (de) | Formulierungen mit gesteuerter freisetzung für schwerlösliche arzneistoffe | |
HUT56267A (en) | Process for producing pharmaceutical compositions having controlled release of active ingredient | |
KR900013943A (ko) | 장기작용성 제제용 약제-방출 조절 피복물질 | |
BR9401199A (pt) | Preparados de medicamentos, processo para a preparação de um preparado de medicamento, processo para a preparação de uma formulação de medicamento. | |
BR0211198A (pt) | Composições farmacêuticas e seu uso | |
ATE97572T1 (de) | Azelastin enthaltende arzneimittel mit kontrollierter wirkstoffabgabe. | |
ATE206042T1 (de) | Verfahren zur herstellung von niedrigdosierten arzneimitteln | |
ATE212840T1 (de) | Oral anzuwendende feste arzneizubereitungen mit modulierter wirkstoffabgabe enthaltend nicorandil und verfahren zu deren herstellung | |
ATE110564T1 (de) | Pharmazeutische zusammensetzungen mit verzögerter freisetzung zur oralen verabreichung sowie deren herstellungsverfahren. | |
DE69108976D1 (de) | Neue Polycarbophil enthaltende pharmazeutische Zusammensetzungen und Verfahren zu deren Herstellung. | |
YU25297A (en) | A controlled release formulation for poorly soluble basic drugs |